drug · small molecule
KP-1077
Phase 2updated 3mo agoby $ZVRA ZEVRA THERAPEUTICS, INC.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval, with 1 investigational indication.
targets
Sodium-dependent dopamine transporterSodium-dependent noradrenaline transporter
all catalysts(0)
nothing on the calendar yet
Trials studying KP-1077
- phase4A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD
- phase4Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening
- phase4An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD
- phase2Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 44m ago
Found something off?
comments(0)
5-min edit window · permanent after that